Home > Drug Search >
  • company_query: Akros
  •   > 
Drug Filter
Category:
chemistry (12) biology (17)
Status:
Approved (1) NDA Filing (1) BLA Filing (1) Phase Ⅲ (6) Phase Ⅱ (5) Phase Ⅰ (15)
Clinical Stage:
Pending (6) Active (14) Discontinued (8)
Bio-Type:
Vaccine (9) Animal extract (1) Recombinant cytokines (2) Whole antibody (4)
Indication:
Alzheimer's disease (AD) (2) Atopic dermatitis (1) Breast cancer (1) Coronary artery disease (CAD) (1) Deep vein thrombosis (DVT) (1) Dementia (1) Infections of the eye (1) HCV infection (1) HIV infection (1) Rabies (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Thrombosis (1) Poliomyelitis (1) Psoriasis (1) Rheumatoid arthritis (RA) (2) Smoking cessation (1) Solid tumours (1) Systemic lupus erythematosus (1) Type 2 diabetes (1) Erythema (1) Head and neck cancer (1) Cervical intraepithelial neoplasia (1) Unstable angina (1) Neutropenia (1) Autoimmune diseases (1) Glioblastoma (1) Metastatic cancer (1) Skin hypertrophic scars (1) Skin disorders (2) Human papillomavirus infections (HPV) (1) Immune thrombocytopenic purpura (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top